10s for Tenpoint: Biotech preps for '26 market launch after phase 3 win for combo eye drop
9th January 2025 Uncategorised 0In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients with presbyopia for up to eight hours. More: 10s for Tenpoint: Biotech preps for '26 market launch after phase 3 win for combo
read more